This is the authors' abstract. We don't add key points for this paper.
Dear Editor, We went through the article titled "Clinical profile and visual outcome in patients with traumatic optic neuropathy" by Sujithra et al.[1] This is a well-organized study, and we congratulate the authors for their publication. We have a few observations for the authors. The authors have included 36 eyes of 34 patients with traumatic optic neuropathy (TON). Within the text and in the table for the demographic profile, it has been mentioned that seven patients had a vision of no perception of light (PL), 18 patients had a vision between PL and 3/60, and eight patients had a vision better than 3/60. This comes out to be a total of 33 patients rather than 34. Vision should ideally be described for eyes and not for patients. The authors have also mentioned that some patients with no PL showed improved vision. Some other studies have also reported improvement in vision from no PL in TON cases.[2] It is difficult to fathom the improvement of vision from no PL. Patients with multiple injuries following road traffic accidents may often not be able to respond correctly to visual acuity assessment. In all patients who showed vision improvement, we feel it will be better to mention vision as questionable PL rather than no PL. All patients underwent posterior segment examination, but the fundoscopy findings are not mentioned in the results. It will be informative for the readers to know about the optic disc findings in patients who presented at varied intervals. It has also been mentioned that some patients received conservative treatment. It would be nice if the authors could clearly define this conservative treatment. It will also be informative to know the mean duration of time that elapsed in the >72 h group before they received intravenous methylprednisolone (IVMP). The authors have concluded that irrespective of the presentation time, all patients receiving high-dose steroids showed improved vision. We would like to know the cut-off time of presentation, beyond which there is no indication for high-dose steroids in patients with TON. It will also be informative to know whether patients developed rapid improvement in vision following the completion of three to five doses of IVMP. Vision improvement following TON is gradual, and recovery can continue for months. Visual recovery reported by authors need not be a direct effect of the high-dose steroid therapy. Financial support and sponsorship: Nil. Conflicts of interest: There are no conflicts of interest.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Panigrahi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: